Macrophages Chase Neutrophils Away From Wounds to Resolve Inflammation

Article

Macrophages are best known for their Pac Man-like ability to gobble up cellular debris and pathogens in order to thwart infection. A new study in the Journal of Cell Biology describes how these immune cells also help resolve inflammation by inducing white blood cells called neutrophils to leave wounded tissue.

Neutrophils are "first responders" that are attracted to wounds by signaling molecules called reactive oxygen species (ROS) that activate a protein kinase. When neutrophils finish their work, inflammation is partly resolved through apoptosis, or cell suicide, and the subsequent engulfment of the neutrophils' remains by macrophages. But neutrophils can also elect to leave wounded tissue in a process known as reverse migration. Whether macrophages promote this mode of inflammation resolution is unclear.

Taking advantage of transparent zebrafish larvae, Anna Huttenlocher and colleagues from the University of Wisconsin-Madison found that neutrophils were generally recruited to wounds before macrophages, but, once they arrived, macrophages often contacted neutrophils and appeared to shepherd them away from the damaged tissue. Neutrophils remained in wounds for longer times in zebrafish larvae lacking macrophages, the researchers discovered. Like neutrophils, macrophages were attracted to wounds by ROS and protein kinase signaling, and macrophages lacking the ROS-generating enzyme Nox2 were unable to migrate into wounds and induce the departure of neutrophils.
 
Interestingly, patients lacking the human equivalent of Nox2 suffer from recurring infections and exaggerated inflammation, a disorder known as chronic granulomatous disease. This new study suggests that one cause of the patients' symptoms may be the inability of macrophages to migrate to sites of inflammation to induce neutrophil reverse migration and inflammation resolution.

Reference: Tauzin S, et al. 2014. J. Cell Biol. doi:10.1083/jcb.201408090

Source: Rockefeller University Press

Related Videos
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Related Content